Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy

Overview of attention for article published in Lung Cancer (01695002), September 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

policy: 1 policy source
patent: 1 patent

guideline: 2 clinical guideline sources

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 2 Guidelines that reference this research output.

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

Clinical guideline published by British Thoracic Society (BTS) on 14 Feb 2018

The British Thoracic Society (BTS) is a registered charity and company limited by guarantee that works to improve standards of care for people who have respiratory diseases, and to support and develop those who provide that care.

NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.

Clinical guideline published by National Comprehensive Cancer Network (NCCN) on 12 Jul 2016

The National Comprehensive Cancer Network (NCCN) is a non-profit alliance of 33 leading cancer centers focused on enhancing patient care, research, and education. It aims to improve cancer care quality and accessibility through comprehensive guidelines and resources for clinicians and patients.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.